As a result, the items purchased on this website may differ from those available on other platforms
Understanding how to initiate, titrate, and monitor these agents can help optimize patient outcomes across multiple domains
Get more insights with our podcast Gain unique and valuable insights from Wellmark when you listen to our monthly Health Matters podcast
Advances in oral delivery of peptide-based medications have resulted in the development of an oral formulation of semaglutide (Rybelsus) which was recently approved by the FDA for the treatment of T2DM
She works for Buffalo Nutrition and Dietetics, PLLC, specializing in gastrointestinal and pediatric nutrition, out of their Sterling Medical Center office in Orchard Park, NY
Published online January 16, 2026